Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Pharmerging
Revenue, means the sales value of Pharmerging
This report studies Pharmerging in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
AstraZeneca
GlaxoSmithKline
Pfizer
Sanofi
Novartis
Abbott Laboratories
Shire
Bayer
Biogen
F. Hoffmann-La Roche
Johnson & Johnson
Mitsubishi Tanabe Pharma
Novo Nordisk
Sun Pharmaceutical
Takeda Pharma
Teva Pharmaceutical Industries
Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Tier 1
Tier 2
Tier 3
Split by Application, this report focuses on consumption, market share and growth rate of Pharmerging in each application, can be divided into
Lung Cancer
Breast Cancer
Chronic Myeloid Leukemia
Lymphomas
Other
China Pharmerging Market Research Report 2017
1 Pharmerging Market Overview
1.1 Product Overview and Scope of Pharmerging
1.2 Pharmerging Segment by Type
1.2.1 China Production Market Share of Pharmerging Type in 2015
1.2.2 Tier 1
1.2.3 Tier 2
1.2.4 Tier 3
1.3 Applications of Pharmerging
1.3.1 Pharmerging Consumption Market Share by Application in 2015
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Chronic Myeloid Leukemia
1.3.5 Lymphomas
1.3.6 Other
1.4 China Market Size (Value) of Pharmerging (2012-2022)
1.5 China Pharmerging Status and Outlook
1.6 Government Policies
2 China Pharmerging Market Competition by Manufacturers
2.1 China Pharmerging Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Pharmerging Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Pharmerging Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Pharmerging Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pharmerging Market Competitive Situation and Trends
2.5.1 Pharmerging Market Concentration Rate
2.5.2 Pharmerging Market Share of Top 3 and Top 5 Manufacturers
3 China Pharmerging Manufacturers Profiles/Analysis
3.1 AstraZeneca
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Pharmerging Product Type, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 AstraZeneca Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 GlaxoSmithKline
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Pharmerging Product Type, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 GlaxoSmithKline Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Pfizer
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Pharmerging Product Type, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Pfizer Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Sanofi
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Pharmerging Product Type, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 Sanofi Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Novartis
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Pharmerging Product Type, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Novartis Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Abbott Laboratories
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Pharmerging Product Type, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 Abbott Laboratories Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Shire
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Pharmerging Product Type, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 Shire Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Bayer
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Pharmerging Product Type, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Bayer Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Biogen
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Pharmerging Product Type, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Biogen Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 F. Hoffmann-La Roche
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Pharmerging Product Type, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 F. Hoffmann-La Roche Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Johnson & Johnson
3.12 Mitsubishi Tanabe Pharma
3.13 Novo Nordisk
3.14 Sun Pharmaceutical
3.15 Takeda Pharma
3.16 Teva Pharmaceutical Industries
4 China Pharmerging Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Pharmerging Capacity, Production and Growth (2012-2017)
4.2 China Pharmerging Revenue and Growth (2012-2017)
4.3 China Pharmerging Production, Consumption, Export and Import (2012-2017)
5 China Pharmerging Production, Revenue (Value), Price Trend by Type
5.1 China Pharmerging Production and Market Share by Type (2012-2017)
5.2 China Pharmerging Revenue and Market Share by Type (2012-2017)
5.3 China Pharmerging Price by Type (2012-2017)
5.4 China Pharmerging Production Growth by Type (2012-2017)
6 China Pharmerging Market Analysis by Application
6.1 China Pharmerging Consumption and Market Share by Application (2012-2017)
6.2 China Pharmerging Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries
7 ChinaPharmerging Market Analysis by Regions (Provinces)
7.1 China Pharmerging Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Pharmerging Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Pharmerging Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Pharmerging Sales Price by Regions (Provinces)(2012-2017)
7.2 China Pharmerging Consumption by Regions (Provinces)(2012-2017)
7.3 China Pharmerging Production, Consumption, Export and Import (2012-2017)
8 Pharmerging Manufacturing Cost Analysis
8.1 Pharmerging Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Pharmerging
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Pharmerging Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Pharmerging Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 China Pharmerging Market Forecast (2017-2022)
12.1 China Pharmerging Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Pharmerging Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Pharmerging Production Forecast by Type (2017-2022)
12.4 China Pharmerging Consumption Forecast by Application (2017-2022)
12.5 China Pharmerging Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Pharmerging Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Pharmerging Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Pharmerging Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Pharmerging Price Forecast (2017-2022)
13 Research Findings and Conclusion
14 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Pharmerging
Figure China Production Market Share of Pharmerging by Type in 2015
Figure Product Picture of Tier 1
Table Major Manufacturers of Tier 1
Figure Product Picture of Tier 2
Table Major Manufacturers of Tier 2
Figure Product Picture of Tier 3
Table Major Manufacturers of Tier 3
Table Pharmerging Consumption Market Share by Application in 2015
Figure Lung Cancer Examples
Figure Breast Cancer Examples
Figure Chronic Myeloid Leukemia Examples
Figure Lymphomas Examples
Figure Other Examples
Figure China Pharmerging Revenue (Million USD) and Growth Rate (2012-2022)
Table China Pharmerging Capacity of Key Manufacturers (2015 and 2016)
Table China Pharmerging Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Pharmerging Capacity of Key Manufacturers in 2015
Figure China Pharmerging Capacity of Key Manufacturers in 2016
Table China Pharmerging Production of Key Manufacturers (2015 and 2016)
Table China Pharmerging Production Share by Manufacturers (2015 and 2016)
Figure 2015 Pharmerging Production Share by Manufacturers
Figure 2016 Pharmerging Production Share by Manufacturers
Table China Pharmerging Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Pharmerging Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Pharmerging Revenue Share by Manufacturers
Table 2016 China Pharmerging Revenue Share by Manufacturers
Table China Market Pharmerging Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Pharmerging Average Price of Key Manufacturers in 2015
Table Manufacturers Pharmerging Manufacturing Base Distribution and Sales Area
Table Manufacturers Pharmerging Product Type
Figure Pharmerging Market Share of Top 3 Manufacturers
Figure Pharmerging Market Share of Top 5 Manufacturers
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Pharmerging Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Pharmerging Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Pharmerging Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Pharmerging Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Pharmerging Market Share (2012-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories Pharmerging Market Share (2012-2017)
Table Shire Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shire Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Shire Pharmerging Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Pharmerging Market Share (2012-2017)
Table Biogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Biogen Pharmerging Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Pharmerging Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Pharmerging Capacity, Production and Growth (2012-2017)
Figure China Pharmerging Revenue (Million USD) and Growth (2012-2017)
Table China Pharmerging Production, Consumption, Export and Import (2012-2017)
Table China Pharmerging Production by Type (2012-2017)
Table China Pharmerging Production Share by Type (2012-2017)
Figure Production Market Share of Pharmerging by Type (2012-2017)
Figure 2015 Production Market Share of Pharmerging by Type
Table China Pharmerging Revenue by Type (2012-2017)
Table China Pharmerging Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Pharmerging by Type (2012-2017)
Figure 2015 Revenue Market Share of Pharmerging by Type
Table China Pharmerging Price by Type (2012-2017)
Figure China Pharmerging Production Growth by Type (2012-2017)
Table China Pharmerging Consumption by Application (2012-2017)
Table China Pharmerging Consumption Market Share by Application (2012-2017)
Figure China Pharmerging Consumption Market Share by Application in 2015
Table China Pharmerging Consumption Growth Rate by Application (2012-2017)
Figure China Pharmerging Consumption Growth Rate by Application (2012-2017)
Table China Pharmerging Production by Regions (Provinces)(2012-2017)
Table China Pharmerging Production Market Share by Regions (Provinces)(2012-2017)
Table China Pharmerging Production Value by Regions (Provinces)(2012-2017)
Table China Pharmerging Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Pharmerging Sales Price by Regions (Provinces)(2012-2017)
Table China Pharmerging Consumption by Regions (Provinces)(2012-2017)
Table China Pharmerging Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Pharmerging Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pharmerging
Figure Manufacturing Process Analysis of Pharmerging
Figure Pharmerging Industrial Chain Analysis
Table Raw Materials Sources of Pharmerging Major Manufacturers in 2015
Table Major Buyers of Pharmerging
Table Distributors/Traders List
Figure China Pharmerging Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Pharmerging Revenue and Growth Rate Forecast (2017-2022)
Table China Pharmerging Production, Import, Export and Consumption Forecast (2017-2022)
Table China Pharmerging Production Forecast by Type (2017-2022)
Table China Pharmerging Consumption Forecast by Application (2017-2022)
Table China Pharmerging Production Forecast by Regions (Provinces)(2017-2022)
Table China Pharmerging Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Pharmerging Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...